The emerging markets represent an attractive investment opportunity for the pharmaceutical industry because of the countries' growing economies and unmet medical needs.
Sandy Macrae
Advertisement
Sandy Macrae is Senior Vice President APJEM R&D, world-wide business development, GlaxoSmithKline (USA). Tel. +1 610 270 5659 Sandy.Macrae@gsk.com
Articles by Sandy Macrae
Advertisement
Latest Updated Articles
- Do emerging markets provide the answer to the pharmaceutical industry?
Published: May 1st 2010 | Updated:
Advertisement
Advertisement
